Exploration of factors influencing pulmonary injury in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis and construction of a predictive model

Using standard clinical markers, we created and internally verified a pragmatic prediction model for pulmonary involvement in AAV. Personalized monitoring and early risk categorization may benefit from this approach. To verify its generalizability, external validation in prospective, multi-center cohorts is advised.